QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARESQUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARESQUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES

QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪11.32 M‬CAD
−20.25CAD
‪−24.61 M‬CAD
0.00CAD
‪1.59 M‬
Beta (1Y)
2.62

About QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES


CEO
Zeeshan Saeed
Headquarters
Toronto
Founded
1994
FIGI
BBG00L1C7X23
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of QNTM is 5.94 CAD — it has increased by 1.69% in the past 24 hours. Watch QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stocks are traded under the ticker QNTM.
QNTM stock has risen by 0.84% compared to the previous week, the month change is a −17.24% fall, over the last year QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES has showed a −93.28% decrease.
We've gathered analysts' opinions on QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES future price: according to them, QNTM price has a max estimate of 17.92 CAD and a min estimate of 17.92 CAD. Watch QNTM chart and read a more detailed QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stock forecast: see what analysts think of QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES and suggest that you do with its stocks.
QNTM reached its all-time high on Sep 20, 2018 with the price of 12,281.10 CAD, and its all-time low was 4.85 CAD and was reached on Sep 3, 2024. View more price dynamics on QNTM chart.
See other stocks reaching their highest and lowest prices.
QNTM stock is 10.10% volatile and has beta coefficient of 2.62. Track QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stock price on the chart and check out the list of the most volatile stocks — is QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES there?
Yes, you can track QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES financials in yearly and quarterly reports right on TradingView.
QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
QNTM earnings for the last quarter are −3.89 CAD per share, whereas the estimation was −3.75 CAD resulting in a −3.90% surprise. The estimated earnings for the next quarter are −1.12 CAD per share. See more details about QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES earnings.
QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES revenue for the last quarter amounts to 0.00 CAD, despite the estimated figure of 0.00 CAD. In the next quarter, revenue is expected to reach ‪1.33 M‬ CAD.
QNTM net income for the last quarter is ‪−5.22 M‬ CAD, while the quarter before that showed ‪−4.26 M‬ CAD of net income which accounts for −22.60% change. Track more QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES financial stats to get the full picture.
No, QNTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QNTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES stock shows the sell signal. See more of QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.